Daytime Compared With Nighttime Differences in Management and Outcomes of Postpartum Hemorrhage.
Journal
Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
pubmed:
12
12
2018
medline:
17
10
2019
entrez:
12
12
2018
Statut:
ppublish
Résumé
To assess whether postpartum hemorrhage management or subsequent morbidity differs based on whether delivery occurred during the day or night. We conducted a secondary analysis of a multicenter observational obstetric cohort of more than 115,000 mother-neonate pairs from 25 hospitals (2008-2011). This analysis included women delivering singleton or twin births who experienced postpartum hemorrhage (estimated blood loss greater than 500 cc for vaginal delivery, estimated blood loss greater than 1,000 cc for cesarean delivery, or documented treatment for postpartum hemorrhage). Nighttime delivery was defined as that occurring between 8 PM and 6 AM. The primary outcome was a composite of maternal morbidity (death, hysterectomy, intensive care unit admission, transfusion, or unanticipated procedure for bleeding). Secondary outcomes included estimated blood loss, uterotonic use, and procedures to treat bleeding that occurred during the postpartum hospitalization. Multivariable logistic, linear, quantile, and multinomial regression models were used to assess associations between nighttime delivery and outcomes, adjusting for potential patient-level confounders and hospital as a fixed effect. In total, 2,709 (34.2%) of 7,917 women with postpartum hemorrhage delivered at night. Women who delivered at night were younger, had a lower body mass index, and were more likely to have government-sponsored insurance, be nulliparous, have hypertension, use neuraxial analgesia, and deliver vaginally. After adjusting for potential confounders, the primary composite outcome of maternal morbidity was similar regardless of night compared with day delivery (15.5% night vs 17.5% day; adjusted odds ratio 0.89, 95% CI 0.77-1.03). Some secondary outcomes, including mean EBL, frequency of uterotonic use, and time from delivery to first uterotonic dose, differed on unadjusted analyses, but these associations did not persist in multivariable analysis. The study had limited power to assess differences in uncommon outcomes. Nighttime delivery was not associated with significant differences in postpartum hemorrhage-related management or morbidity.
Identifiants
pubmed: 30531567
doi: 10.1097/AOG.0000000000003033
pmc: PMC6309479
mid: NIHMS1510370
pii: 00006250-201901000-00021
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
155-162Subventions
Organisme : NICHD NIH HHS
ID : U10 HD053118
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024989
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD040500
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD027869
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD040544
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025764
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD034116
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD040560
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD053097
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD027915
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD040485
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD040544
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD034208
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD040512
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD034116
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD027869
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD027917
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD027915
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD040545
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD040485
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD040560
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD034208
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD053097
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD040500
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD040512
Pays : United States
Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD021410
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD036801
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD040545
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD036801
Pays : United States
Références
BJOG. 2018 Jun;125(7):884-891
pubmed: 29210161
Am J Obstet Gynecol. 2010 Apr;202(4):353.e1-6
pubmed: 20350642
Am J Obstet Gynecol. 2017 Jan;216(1):75.e1-75.e6
pubmed: 27589899
Am J Obstet Gynecol. 2014 Aug;211(2):147.e1-147.e16
pubmed: 24631441
Am J Obstet Gynecol. 2015 Nov;213(5):705.e1-11
pubmed: 26196454
Am J Obstet Gynecol. 2013 Nov;209(5):446.e1-446.e30
pubmed: 23891630
Am J Obstet Gynecol. 2015 Feb;212(2):140-4.e1
pubmed: 25019484
Am J Obstet Gynecol. 2006 Oct;195(4):1132-7
pubmed: 16875648
J Matern Fetal Neonatal Med. 2011 Aug;24(8):1051-4
pubmed: 21231839
Am J Obstet Gynecol. 2013 Nov;209(5):449.e1-7
pubmed: 23871950
Obstet Gynecol. 2006 Oct;108(4):1039-47
pubmed: 17012482
Obstet Gynecol. 2017 Oct;130(4):e168-e186
pubmed: 28937571
BJOG. 2018 Jun;125(7):892
pubmed: 29160032